Dario Amodei Defends Anthropic's AI Regulation Stance Amid Trust Debate

Amodei's core defense is architectural: SB53 exempts companies with combined annual revenue under $500 million from its enhanced large-developer obligations ^[3], and requires critical safety incidents to be reported to the state within 15 days ^[4]. He calls this a design meant to disadvantage frontier labs like Anthropic itself while sparing smaller competitors, and describes the broader shift toward a FINRA-like oversight body plus pre-deployment testing as a meaningful change from an industry that, six months earlier, was mostly asking for state regulation to be repealed outright ^[3]. Critics read the same mechanics in reverse. Washington Examiner contributor Eric Miller argues that the kind of compliance overhead Amodei is describing is out of reach for a small competitor, writing bluntly that a ten-person start-up cannot meet it ^[5]. White House AI and crypto czar David Sacks has gone further, describing Anthropic's advocacy as a sophisticated regulatory capture strategy built on fear-mongering ^[5]. The disagreement is not really about the text of SB53, both sides cite the same $500 million threshold and 15-day window, it is about who a compliance regime built around thresholds and testing ultimately advantages once it exists.

This isn't a new position for Amodei - he's made a similar case in other venues over recent months. On 60 Minutes, confronted with the accusation that his safety framing amounts to 'safety theater,' he countered that Anthropic's claims are verifiable rather than branding, and laid out a 'compressed 21st century' thesis in which AI could deliver cures for most cancers and help prevent Alzheimer's. In a separate clip with Dwarkesh, he defended his opposition to a federal moratorium on state AI laws, distinguishing what he called a 'dumb' Tennessee bill from the broader principle that a blanket ban with no federal backstop would leave real risks unaddressed, a distinction that lines up with the SB53 argument above: regulation done well, not regulation as such, is what he says he's defending.

Amodei's central rebuttal to Baker is a reframing: the backlash against AI isn't a reaction to his specific warnings, it's a symptom of decades-old distrust of companies, governments, and the tech industry generally, one he says predates and exceeds anything he has personally said ^[1]. He also disputes the premise that his messaging skews negative, describing it as roughly balanced between risk and benefit and pointing to his essay Machines of Loving Grace as evidence of the optimistic half of that balance ^[1]. Where he does concede ground is telling: he calls the most accurate criticism of AI companies, Anthropic included, the fact that they haven't yet delivered on the big promises they've made to the public ^[6]. That concession matters because it sets up his entire trust argument, if the industry's credibility problem is really about broken promises rather than excessive candor about risk, then the fix isn't softer messaging, it's shipping results. It's a framing that lets him accept blame for underdelivery while rejecting blame for causing the backlash in the first place, and it's the hinge that has drawn the sharpest pushback.

Having argued that words won't rebuild trust, Amodei stakes his credibility on a single outcome: 'The thing that will work is actually curing cancer' ^[2]. He has separately projected that AI could help cure most diseases, cancer included, within five to ten years ^[7], turning a decades-old aspirational talking point into a testable, dated claim attached to his own name. The claim traveled widely enough to headline threads on three separate subreddits: r/technology's version, 'the way for AI to win over the public is to actually cure cancer,' drew by far the largest engagement at roughly 12,000 upvotes and 2,300 comments, while r/LocalLLaMA's thread on his broader policy defense and r/ArtificialInteligence's thread on the crisis-of-trust framing picked up smaller but still active followings. That spread suggests the cancer-cure line, more than any other part of Amodei's response, is the detail cutting through to a general audience.

The entire episode traces back to a single relayed claim: on the All-In podcast, Gavin Baker cited unnamed sources describing Amodei as having said Anthropic could end up the only private company left standing. Anthropic researcher Sholto Douglas moved fast to knock it down as completely false, arguing no government should let any single company accumulate that much influence and that competition and capitalism are the actual goal ^[6]. David Sacks piled on, calling the underlying claim hubristic even as he used the moment to reiterate his separate regulatory capture accusation against the company ^[6]. Baker's own response to Douglas's denial reframed the argument rather than dropping it: he thanked Douglas for correcting the record but noted that many serious people in Silicon Valley had heard and believed some version of the claim precisely because it fit Amodei's existing public messaging on power concentration. One prominent rebuttal on X to Amodei's own thread called it a masterclass in having it both ways, arguing he can't simultaneously say frontier AI structurally concentrates power and insist that rules he helped design will keep that concentration in check rather than lock it in around his own company.